{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"charcot-marie-tooth-disease-dominant-intermediate-e","columns":[{"gene":"","key":"population-3f0bf5c9e9a2566e3897","label":"Charcot-Marie-Tooth disease, dominant intermediate E","mondoId":"MONDO:0013758","onsetQualifier":null,"originColumnKey":"MONDO:0013758/OMIM:614455","originalViews":[{"key":"MONDO:0013758/OMIM:614455","label":"Charcot-Marie-Tooth disease, dominant intermediate E","scopeLabel":"OMIM:614455","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["1769f6a6ee333ff7f184eace441b6cfd4909e4e514d81bcb38896e39cdd24fe1","22830de4666d207cd895b7d12798bf23ce18e17f466a747028a1c2e159b466e4","31118aa9e356961b788f77c78ba400a65e648b4d6ecaa97f16bd29e58bc862b8","38eee101a289fee7578c3df8966764028d78476c373728616ca396b82230a395","3d7ae94614f5a8e3d67015b16da88e42ad7af59847949aa8bfe096672bb0e12c","4a8404a4e0eec09af9ecc042295656221b2403064d7608f5b7129e3e2a0dc478","4a89c9bdd327b0004acb45dcc9b1647078de4cd7cd526662accc9baf36633c52","55603e12f3de58263498c1eaf3824c8ba804efa227515f49dc26313f9fc24e51","6c91b2f94f69329520a2d0ba3fc304af1260a50c58285210a508e2374060d238","8e712157052b20ed861ccf93da9c4234441bc015184ee83691ad1a9a94eb85e2","95104e4d4537f0bd942d215380e9d5ce0e48959a436b79f56765336529f491b7","a5adea67e3a04e370a69f0ec7a308436ff65fee6c863c9f82e9cc1afdd5e54f6","a7a16739d662c780ce7fcf386b2bee4bf41b51abdf1cf557b5132a3bce88b20b","a849ed97b65ab91a60e95bcc6273a7a79259f67c17ccfd49c80d59faee3f26b4","c10bcbeaddfcb3b8dd6bd117a8c53be8f70230c9ef14a310d00180dac5efe6c5","d0004b36997962cb2c30ff29038f166d4f72db0c5c8642f1acd1844bbe165983","d77d2f42b14d7a2b49b620843268206b26efdfcf2d1c13ada390a8d1897f9390","de17e2a65b36d751d22a266f1730ab696be2307586181adfc2b9060b84eec218","eae948ad99910ead4f2a80c1687ae27c32ab3ffaca14de02b148e58403425b39"],"recordQualifiers":{},"scopeLabel":"OMIM:614455","sourceIds":["OMIM:614455"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-3f0bf5c9e9a2566e3897"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001284","HP:0003447","HP:0034337","HP:0008944","HP:0002460","HP:0002936","HP:0007149"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"omim":7,"published":12}},"features":[{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0003447","label":"Axonal loss","primary":true},{"hpoId":"HP:0034337","label":"Claw hand deformity","primary":true},{"hpoId":"HP:0008944","label":"Distal lower limb amyotrophy","primary":true},{"hpoId":"HP:0002460","label":"Distal muscle weakness","primary":true},{"hpoId":"HP:0002936","label":"Distal sensory impairment","primary":true},{"hpoId":"HP:0007149","label":"Distal upper limb amyotrophy","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0000097","label":"Focal segmental glomerulosclerosis","primary":false},{"hpoId":"HP:0009027","label":"Foot dorsiflexor weakness","primary":false},{"hpoId":"HP:0001765","label":"Hammertoe","primary":false},{"hpoId":"HP:0001265","label":"Hyporeflexia","primary":false},{"hpoId":"HP:0003383","label":"Onion bulb formation","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0001761","label":"Pes cavus","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0003774","label":"Stage 5 chronic kidney disease","primary":false},{"hpoId":"HP:0003376","label":"Steppage gait","primary":false}],"ledeHtml":"A rare hereditary motor and sensory neuropathy disorder characterized by the typical CMT phenotype (slowly progressive distal muscle weakness and atrophy in upper and lower limbs, distal sensory loss in extremities, reduced or absent deep tendon reflexes and foot deformities) associated with focal segmental glomerulosclerosis (manifesting with proteinuria and progression to end-stage renal disease). Mild or moderate sensorineural hearing loss may also be associated. Nerve biopsy reveals both axonal and demyelinating changes and nerve conduction velocities vary from the demyelinating to axonal range (typically between 25-50m/sec).","mondoId":"MONDO:0013758","node":{"canonicalSlug":"charcot-marie-tooth-disease-dominant-intermediate-e","comparisons":[{"documentSha256":"50851a7da40b057e769a968fb25f76a08acc90b153c0e816948fc8134b41ab0c","key":"expanded-charcot-marie-tooth-disease","kind":"expanded","label":"Charcot-Marie-Tooth disease","memberIds":["MONDO:0007307","MONDO:0007308","MONDO:0007309","MONDO:0007310","MONDO:0007311","MONDO:0007312","MONDO:0007790","MONDO:0008451","MONDO:0008961","MONDO:0010479","MONDO:0010549","MONDO:0010550","MONDO:0010551","MONDO:0010689","MONDO:0010699","MONDO:0010949","MONDO:0010995","MONDO:0011002","MONDO:0011066","MONDO:0011085","MONDO:0011091","MONDO:0011113","MONDO:0011475","MONDO:0011527","MONDO:0011534","MONDO:0011569","MONDO:0011570","MONDO:0011633","MONDO:0011674","MONDO:0011675","MONDO:0011687","MONDO:0011889","MONDO:0011890","MONDO:0011894","MONDO:0011898","MONDO:0011901","MONDO:0011902","MONDO:0011903","MONDO:0011909","MONDO:0011916","MONDO:0012012","MONDO:0012014","MONDO:0012096","MONDO:0012231","MONDO:0012250","MONDO:0012411","MONDO:0012640","MONDO:0013212","MONDO:0013338","MONDO:0013644","MONDO:0013753","MONDO:0013758","MONDO:0013959","MONDO:0014012","MONDO:0014074","MONDO:0014117","MONDO:0014154","MONDO:0014208","MONDO:0014467","MONDO:0014511","MONDO:0014566","MONDO:0014665","MONDO:0014711","MONDO:0014726","MONDO:0014733","MONDO:0014735","MONDO:0014736","MONDO:0014836","MONDO:0014906","MONDO:0015626","MONDO:0016431","MONDO:0016454","MONDO:0017058","MONDO:0017937","MONDO:0017940","MONDO:0018567","MONDO:0018776","MONDO:0018778","MONDO:0018993","MONDO:0018994","MONDO:0018995","MONDO:0019011","MONDO:0019548","MONDO:0020558","MONDO:0025622","MONDO:0030433","MONDO:0030458","MONDO:0030677","MONDO:0030689","MONDO:0031068","MONDO:0032728","MONDO:0033135","MONDO:0036484","MONDO:0044625","MONDO:0044640","MONDO:0044657","MONDO:0054833","MONDO:0859311","MONDO:0957273","MONDO:0976227"],"mondoId":"MONDO:0015626","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-50851a7da40b057e769a.50851a7da40b057e769a968fb25f76a08acc90b153c0e816948fc8134b41ab0c.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Charcot-Marie-Tooth disease dominant intermediate E","originalSourceId":"ORPHA:93114","paragraphs":["A rare hereditary motor and sensory neuropathy disorder characterized by the typical CMT phenotype (slowly progressive distal muscle weakness and atrophy in upper and lower limbs, distal sensory loss in extremities, reduced or absent deep tendon reflexes and foot deformities) associated with focal segmental glomerulosclerosis (manifesting with proteinuria and progression to end-stage renal disease). Mild or moderate sensorineural hearing loss may also be associated. Nerve biopsy reveals both axonal and demyelinating changes and nerve conduction velocities vary from the demyelinating to axonal range (typically between 25-50m/sec)."],"rawAttribution":"MONDO:0013758","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:31Z","upstream":"MONDO:0013758","url":"https://rarediseases.info.nih.gov/diseases/12011"},"ownColumnKeys":["population-3f0bf5c9e9a2566e3897"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal dominant intermediate Charcot-Marie-Tooth disease","mondoId":"MONDO:0019548","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"count","key":"1769f6a6ee333ff7f184eace441b6cfd4909e4e514d81bcb38896e39cdd24fe1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"22830de4666d207cd895b7d12798bf23ce18e17f466a747028a1c2e159b466e4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009027","is_excluded":false,"label":"Foot dorsiflexor weakness","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"31118aa9e356961b788f77c78ba400a65e648b4d6ecaa97f16bd29e58bc862b8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001265","is_excluded":false,"label":"Hyporeflexia","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"38eee101a289fee7578c3df8966764028d78476c373728616ca396b82230a395","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002936","is_excluded":false,"label":"Distal sensory impairment","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"3d7ae94614f5a8e3d67015b16da88e42ad7af59847949aa8bfe096672bb0e12c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4a8404a4e0eec09af9ecc042295656221b2403064d7608f5b7129e3e2a0dc478","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000097","is_excluded":false,"label":"Focal segmental glomerulosclerosis","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"4a89c9bdd327b0004acb45dcc9b1647078de4cd7cd526662accc9baf36633c52","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0008944","is_excluded":false,"label":"Distal lower limb amyotrophy","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"55603e12f3de58263498c1eaf3824c8ba804efa227515f49dc26313f9fc24e51","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"4/12","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6c91b2f94f69329520a2d0ba3fc304af1260a50c58285210a508e2374060d238","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"11/12","hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8e712157052b20ed861ccf93da9c4234441bc015184ee83691ad1a9a94eb85e2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001761","is_excluded":false,"label":"Pes cavus","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"95104e4d4537f0bd942d215380e9d5ce0e48959a436b79f56765336529f491b7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"5/11","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a5adea67e3a04e370a69f0ec7a308436ff65fee6c863c9f82e9cc1afdd5e54f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a7a16739d662c780ce7fcf386b2bee4bf41b51abdf1cf557b5132a3bce88b20b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0034337","is_excluded":false,"label":"Claw hand deformity","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a849ed97b65ab91a60e95bcc6273a7a79259f67c17ccfd49c80d59faee3f26b4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0002460","is_excluded":false,"label":"Distal muscle weakness","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c10bcbeaddfcb3b8dd6bd117a8c53be8f70230c9ef14a310d00180dac5efe6c5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003376","is_excluded":false,"label":"Steppage gait","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d0004b36997962cb2c30ff29038f166d4f72db0c5c8642f1acd1844bbe165983","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003383","is_excluded":false,"label":"Onion bulb formation","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d77d2f42b14d7a2b49b620843268206b26efdfcf2d1c13ada390a8d1897f9390","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001765","is_excluded":false,"label":"Hammertoe","onset_id":null,"reference":"OMIM:614455","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"de17e2a65b36d751d22a266f1730ab696be2307586181adfc2b9060b84eec218","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003447","is_excluded":false,"label":"Axonal loss","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eae948ad99910ead4f2a80c1687ae27c32ab3ffaca14de02b148e58403425b39","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614455","disease_name":"Charcot-Marie-Tooth disease, dominant intermediate E","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0007149","is_excluded":false,"label":"Distal upper limb amyotrophy","onset_id":null,"reference":"PMID:22187985","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12011\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013758\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0013758</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare hereditary motor and sensory neuropathy disorder characterized by the typical CMT phenotype (slowly progressive distal muscle weakness and atrophy in upper and lower limbs, distal sensory loss in extremities, reduced or absent deep tendon reflexes and foot deformities) associated with focal segmental glomerulosclerosis (manifesting with proteinuria and progression to end-stage renal disease). Mild or moderate sensorineural hearing loss may also be associated. Nerve biopsy reveals both axonal and demyelinating changes and nerve conduction velocities vary from the demyelinating to axonal range (typically between 25-50m/sec).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12011\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"charcot-marie-tooth-disease-dominant-intermediate-e","sourceDocuments":[{"name":"GARD: Charcot-Marie-Tooth disease dominant intermediate E","reviewed":null,"source_release":"2026-10-25T03:41:31Z","url":"https://rarediseases.info.nih.gov/diseases/12011"},{"name":"MONDO: Charcot-Marie-Tooth disease dominant intermediate E","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013758"}],"sourceNote":"","synonyms":["autosomal dominant intermediate Charcot-Marie-Tooth disease type E","Charcot-Marie-Tooth disease - nephropathy","Charcot-Marie-Tooth disease dominant intermediate E","Charcot-Marie-Tooth disease dominant intermediate type E","Charcot-Marie-Tooth disease, dominant intermediate E","Charcot-Marie-Tooth disease, dominant Intermediate type E","Charcot-Marie-Tooth disease-nephropathy syndrome","Charcot-Marie-Tooth neuropathy with focal segmental glomerulonephritis","CMTDIE"],"takeawayHtml":"","title":"Charcot-Marie-Tooth disease dominant intermediate E"},"schemaVersion":1}
